Welcome to the U.S. Hereditary Angioedema Association's website. We are a non-profit patient advocacy organization dedicated to expediting US approval of safer and more effective HAE therapies. In addition, we provide a wide range of services that include clinical trial placement, physician referrals, education, and individualized patient case management. Please click here and fill out a short form so we can provide you with the latest information regarding new HAE treatments and events sponsored by the HAE Association.
Please participate in the following survey:
 Insurance Survey |
  Bring much-needed HAE treatment to the US. Sign up to participate in the clinical trials  Register to be a member of our message forum and be a part of the HAEA online community.Frequently Asked Questions About HAE Everything you need to know about HAE diagnosis and treatment Angioedema Table Find out the difference between the different types of Angioedema New Treatment Options Learn about the ongoing clinical trials which will revolutionize the way HAE attacks are treated. Physician Referral Find a physician near you. HAE Patient Email Support Group Reach out to other HAE patients by subscribing to our message forum Be part of our Volunteer Network! Join our network of HAE patients who are motivated to help serve our patient community. |
 Jul 16, 2008 - InvestSource Inc.: Lev Pharmaceuticals Acquired by ViroPharma Jul 15, 2008 - Jerini Receives European Commission Approval for FIRAZYR(R) (Icatibant) in the Treatment of HAE Jul 11, 2008 - Pharming says ongoing open-label studies with Rhucin show positive results HAEA NewsJune 2008 - Read our June 2008 Newsletter October 2007 - Highlights from the 2007 HAEA Patient National Conference in St.Louis, MO eBay users, here's a new way to give!  Buy or sell on eBay and support HAEA.com. |
